Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access               Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain HOLX message board posts where the ticker symbol HOLX has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest HOLX SEC Filings

Filings Format Description Filing Date File/Film Number
SD  Documents Acc-no: 0000859737-18-000009 (34 Act)  Size: 375 KB 2018-05-31 001-36214
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-019243 Size: 15 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-019240 Size: 8 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-019238 Size: 7 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-016388 Size: 13 KB
S-8  Documents Securities to be offered to employees in employee benefit plans
Acc-no: 0000859737-18-000007 (33 Act)  Size: 126 KB
2018-05-02 333-224613
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0000859737-18-000006 (34 Act)  Size: 9 MB
2018-05-02 001-36214
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001144204-18-024760 (34 Act)  Size: 957 KB
2018-05-02 001-36214
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-18-004866 (34 Act)  Size: 14 KB
2018-04-16 001-36214
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-012282 Size: 4 KB
More HOLX SEC Filings

Related news from
Mon, 18 Jun 2018
12:06:00 +0000
Hologic's New Panther Fusion® System, Flu and Respiratory Assays Now Approved by Health Canada
MARLBOROUGH, Mass. , June 18, 2018 /PRNewswire/ -- Hologic, Inc. (HOLX) announced today that it has obtained approval from Health Canada for its new Panther Fusion® system and Panther Fusion assays for respiratory virus infections. The Fusion module offers laboratories the ability to extend the testing capabilities of the existing Panther system. The Panther Fusion module is an in-lab upgrade to the Panther® instrument.  This addition adds the flexibility of PCR (polymerase chain reaction) to the proven performance of TMA (transcription-mediated amplification), which is used by the Panther system.   Offering labs multiple chemistries on a single platform enables further consolidation of lab testing.
Mon, 18 Jun 2018
12:00:00 +0000
LexaGene Names Medical Device Veteran Joseph Caruso to Board of Directors
LexaGene Holdings Inc. (LXXGF) (LXG.V) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, today announced the appointment of Joseph Caruso, to the Company’s Board of Directors.  “Mr. Caruso is joining LexaGene’s Board of Directors at a pivotal moment for the Company, as we are continuing to push forward with the optimization of our first-of-its-kind prototype for rapid pathogen detection,” said Dr. Jack Regan, LexaGene’s CEO.
Tue, 12 Jun 2018
11:50:00 +0000
Detailed Research: Economic Perspectives on Amphenol, Hologic, Newell Brands, Ciena, SAExploration, and Puma Biotechnology — What Drives Growth in Today's Competitive Landscape
NEW YORK, June 12, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Amphenol ...
Tue, 12 Jun 2018
11:10:00 +0000
Complimentary Technical Snapshots on Hologic and Three More Medical Supplies Stocks
Lined up for assessment this morning are these four equities: Haemonetics Corp. (NYSE: HAE), Hill-Rom Holdings Inc. (NYSE: HRC), Hologic Inc. (NASDAQ: HOLX), and Insulet Corp. (NASDAQ: PODD). Shares in Braintree, Massachusetts headquartered Haemonetics Corp. saw a slight decline of 0.61%, ending Monday’s trading session at $93.47.
Fri, 08 Jun 2018
12:07:22 +0000
See what the IHS Markit Score report has to say about Hologic Inc.
Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 14. Index (PMI) data, output in the Healthcare sector is rising.
Fri, 01 Jun 2018
12:55:12 +0000
Hologic (HOLX) Down 1.6% Since Earnings Report: Can It Rebound?
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thu, 31 May 2018
11:40:00 +0000
Free Research Report as Hologic’s Revenues Jumped 10.3% and Adjusted EPS Climbed 6%
LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free earnings report on Hologic, Inc. (NASDAQ: HOLX), all you need to do is sign up now by clicking the following link The Company reported its second quarter fiscal 2018 operating and financial results on May 02, 2018. is currently working on the research report for BIOLASE, Inc. (NASDAQ: BIOL), which also belongs to the Healthcare sector as the Company Hologic.
Tue, 29 May 2018
20:01:00 +0000
Hologic to Webcast Presentations at Upcoming Investor Conferences
MARLBOROUGH, Mass. , May 29, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The Jefferies Global Healthcare Conference ...
Fri, 11 May 2018
19:47:08 +0000
Edited Transcript of HOLX earnings conference call or presentation 2-May-18 8:30pm GMT
Q2 2018 Hologic Inc Earnings Call
Fri, 11 May 2018
18:42:00 +0000
NYSE trader: Trump will go easy on drug companies, and stocks should be just fine
Alan Valdes, director of floor operations at Silverbear Capital, joins Yahoo Finance's Alexis Christoforous from the floor of the New York Stock Exchange to discuss the latest market moves.
Thu, 03 May 2018
20:29:47 +0000
Tesla and AIG tumble while Kraft Heinz and Kellogg climb
Stocks that moved substantially or traded heavily Thursday: Tesla Inc., down $16.70 to $284.45 The electric car maker took another big quarterly loss as it struggled to ramp up production of its Model ...
Thu, 03 May 2018
18:43:47 +0000
Benzinga's Top Analyst Calls From May 3, 2018
Wayfair Inc (NYSE: W ) - Bank of America on Wednesday upgraded from Neutral To Buy and lifted price target from $90 to $95; Says the company has built "solid scale" in the home goods category. ...
Thu, 03 May 2018
16:07:14 +0000
Leerink Downgrades Hologic After 'Lower Quality' Q2 Revenue Beat
Hologic did report a sales beat in it Q2, but it was driven mostly by breast health sales that benefited from distribution acquisitions, Newitter said in a Thursday note. Molecular diagnostics excluding blood screening fell short of expectations due to poor weather trends, Newitter said. A better-than-expected contribution from blood screening yielded a "lower quality" revenue beat, he said.
Thu, 03 May 2018
13:56:01 +0000
Hologic's (HOLX) Q2 Earnings Meet Estimates, Revenues Top
Solid growth at Hologic's (HOLX) Breast Health and international business drives top line in Q2.
Thu, 03 May 2018
13:14:57 +0000
Hologic Stock Falls Over 9% on 2Q18 Results, Lower 2018 Guidance
Yesterday, after the market closed, Hologic (HOLX) released its 2Q18 earnings results for the quarter that ended on March 31. The company’s reported revenues exceeded analysts’ estimates, but the adjusted EPS (earnings per share) for the quarter barely met Wall Street estimates. For fiscal 2Q18, the company posted revenues of $789.3 million, representing YoY (year-over-year) revenue growth of ~10.3%.
Thu, 03 May 2018
12:31:57 +0000
Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks ( Stocks hitting 52-week highs on May 2 ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Eleven Biotherapeutics ...
Thu, 03 May 2018
12:03:00 +0000
Hologic Receives Health Canada Authorization to Market SculpSure® Laser for Non-Invasive Body Contouring (Lipolysis) of the Back, Inner and Outer Thighs, and Under the Chin
MARLBOROUGH, Mass. , May 3, 2018 /PRNewswire/ -- Hologic, Inc. (HOLX) announced today that it has received a medical device license issued by Health Canada to market Cynosure's advanced non-invasive body contouring product, SculpSure, for treatment of the back, inner and outer thighs, and submental area (under the chin). Importantly, SculpSure laser body treatments (abdomen, flanks, back, inner and outer thigh) are recommended for patients with a body mass index (BMI) of 30 or lower, while SculpSure laser submental treatments (under the chin) have been proven effective on patients with a BMI up to 43. This is a significant advantage over the brand's cryolipolysis competitor, which is only approved to treat patients with a BMI up to 30 in the submental area in the US.
Wed, 02 May 2018
20:14:19 +0000
Hologic: Fiscal 2Q Earnings Snapshot
MARLBOROUGH, Mass. (AP) _ Hologic Inc. (HOLX) on Wednesday reported a fiscal second-quarter loss of $681.4 million, after reporting a profit in the same period a year earlier. The results met Wall Street expectations. For the current quarter ending in July, Hologic expects its per-share earnings to range from 55 cents to 57 cents.
Wed, 02 May 2018
20:01:00 +0000
Hologic Announces Financial Results for Second Quarter of Fiscal 2018
-- Revenue of $789.3 Million Grows 10.3%, 8.3% in Constant Currency -- -- Company Posts GAAP Diluted EPS of ($2.46) Due to Non-Cash Charges, Non-GAAP Diluted EPS of $0.53 -- MARLBOROUGH, Mass. , May 2, ...

"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This is the most knowledgable group I've ever been associated with (23 years). It is also the most unselfish and there is never any name calling or putting members down. ValueForum has helped me be very successful." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards